| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/17/2005 | WO2004099395A3 A method for the generation of neural progenitor cells |
| 03/17/2005 | WO2004032850A3 Uses of human zven antagonists |
| 03/17/2005 | WO2004022729A8 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 03/17/2005 | WO2003101484A9 Compositions and methods for transepithelial molecular transport |
| 03/17/2005 | US20050060779 Lectin-derived progenitor cell preservation factors and methods of use |
| 03/17/2005 | US20050060776 Expression of biologically active polypeptides in duckweed |
| 03/17/2005 | US20050060773 Expression vector comprising nucleotide sequences coding gene associated with plant dwarfing (RHT) for use as tool in establishing seedling development in plants |
| 03/17/2005 | US20050060768 genetic constructs comprising a first lethal gene and a second gene adapted for expression in a plant cell, wherein the second gene confer novel traits to the plants |
| 03/17/2005 | US20050060767 DNA shuffling to produce herbicide selective crops |
| 03/17/2005 | US20050060765 supplements comprising alanyl-glutamine and one or more non-essential amino acids present in amounts that when added to an in vitro fertilization medium prevent osmotic shock of a gamete, zygote or embryo cultured in the in vitro fertilization medium |
| 03/17/2005 | US20050060762 Plasmid construct comprising hybrid alpha -lactalbumin promoter for use as gene transfer and expression tool in genetic engineering; gene therapy and tissue engineering |
| 03/17/2005 | US20050059801 Transmembrane receptor/chemokine receptor for use in identifying modulators for treatment of glomerulonephritis, asthma, inflammatory bowel, transplant rejection and inflammation |
| 03/17/2005 | US20050059633 Novel glucans and novel glucansucrases derived from lactic acid bacteria |
| 03/17/2005 | US20050059628 Modulation of beta-catenin/TCF-activated transcription |
| 03/17/2005 | US20050059618 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis |
| 03/17/2005 | US20050059153 Using electromagnet energy to propagate and stimulate cell growth; regenerative medicine; wound healing agents; tissue engineering and treatment of skin disorders |
| 03/17/2005 | US20050059152 Culturing mesenchymal primordial cell tissues isolated from cord blood into biological scaffolds for use in repairing damaged tissue; regenerative medicies; tissue repair and replacement; tissue engineering |
| 03/17/2005 | US20050059151 Compositions and methods for priming monocytic dendritic cells and t cells for th-1response |
| 03/17/2005 | US20050059150 Providing solid support comprising immobilized extracellular matrix protein and cell adhesion resistant (CAR) material for use as tool in propagation and maintenance hepatic tissues; regenerative medicine; tissue engineering and repair |
| 03/17/2005 | US20050059149 Methods of ex-vivo expansion of hematopoeitic cells using multivariant IL-3 hematopoiesis chimera proteins |
| 03/17/2005 | US20050059148 Wherein cell stressor is light, retinoid, cigarette smoke condensate, increased hydrostatic pressure, or glutamate; neurodegenerative diseases |
| 03/17/2005 | US20050059147 Human mesenchymal progenitor cell |
| 03/17/2005 | US20050059146 Method for recloning production cells |
| 03/17/2005 | US20050059145 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells |
| 03/17/2005 | US20050059144 MHC class II antigen-presenting systems and methods for activating CD4+ T cells |
| 03/17/2005 | US20050059140 Methods of surface modification to enhance cell adhesion |
| 03/17/2005 | US20050059135 Methods and compositions for identifying receptor effectors |
| 03/17/2005 | US20050059132 Variant blood coagulation factor for use as tool in treatment of thrombosis |
| 03/17/2005 | US20050059130 Lipolytic enzyme variants |
| 03/17/2005 | US20050059117 Nucleotide sequences coding endothelial growth factor for use as tools in treatment and prevention of cell prolifreative disorders; antitumor agents |
| 03/17/2005 | US20050059116 Compositions and methods for inhibiting G2 cell cycle arrest and sensitizing cells to DNA damaging agents |
| 03/17/2005 | US20050059115 Using biglycan protein to diagnose, prevent and treatment of cell proliferative disorders |
| 03/17/2005 | US20050059093 Method for detecting modulators of Notch signalling |
| 03/17/2005 | US20050059092 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation |
| 03/17/2005 | US20050059087 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 03/17/2005 | US20050059082 Method for producing protein libraries and for selecting proteins from said libraries |
| 03/17/2005 | US20050059081 Dipeptidyl peptidase IV (DPPIV); homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders; antibodies for therapeutic or diagnostic use; host cells |
| 03/17/2005 | US20050059078 Transgenic cells for use as bioreactors; heterologous gene expression; animal model of disease |
| 03/17/2005 | US20050059073 Expression vector comprising nucleotide sequences coding cell growth factors for use in treatment and prevention of nervous system disorders |
| 03/17/2005 | US20050059061 Beta, beta-carotene 15,15'-enzymes, nucleic acid sequences coding therefor and their use |
| 03/17/2005 | US20050059056 Antigenic gp100 (154-162) compounds for therapy and diagnosis and methods for using same |
| 03/17/2005 | US20050059040 Guidance receptor protein for use as tool in identifying modlator for use in treatment and preventio of nervous system disorders |
| 03/17/2005 | US20050059031 Microcrystal solid support comprising cationic polymers and immobilized nucleotide sequences for use as construct in transfer of heterologous gene sequences |
| 03/17/2005 | US20050059004 Nucleotide sequences coding translational regulatory element comprising adenine rich regions for use in activation of cap-independent translation of a nucleotide sequence of interest in eukaryotic cells or organisms; translation and heterologous gene expression |
| 03/17/2005 | US20050058999 Gene involved in apoptosis regulation |
| 03/17/2005 | US20050058994 Epitopes; immunoglobulins; hybridomas; diagnostic kits |
| 03/17/2005 | US20050058984 Novel methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 03/17/2005 | US20050058983 Immunoglobulin which specifically binds to lymphadenopathy associated viral glycoprotein 120 for use as tool in prevention and treatment of viral infection; immunotherapy |
| 03/17/2005 | US20050058982 Modified small interfering RNA molecules and methods of use |
| 03/17/2005 | US20050058842 Methods of surface modification of a flexible substrate to enhance cell adhesion |
| 03/17/2005 | US20050058726 Incubating bone to loosene associated soft tissue with alkaline solution comprising hydroxide of sodium, potassium, ammonium, or lithium; and/or trisodium phosphate, tripotassioum phosphate and/or triethanolamine |
| 03/17/2005 | US20050058724 Fluid therapy with l-lactate and/or pyruvate anions |
| 03/17/2005 | US20050058692 Biofunctional fibers |
| 03/17/2005 | US20050058687 Covalently attached collagen VI for cell attachment and proliferation |
| 03/17/2005 | US20050058685 Method of immobilization of clusters of ligands on polymer surface and use in cell engineering |
| 03/17/2005 | US20050058668 Allogeneic immunotherapy agent for cancer therapy; vaccine |
| 03/17/2005 | US20050058647 Newly identified polypeptide and polynucleotides for diagnosis of new compounds |
| 03/17/2005 | US20050058645 Antibodies that bind interleukin receptors for treatment of skin disorders, rhinitis, inflammatory bowel disease or breathing disorders |
| 03/17/2005 | US20050058642 Antagonists and agonists of LDCAM and methods of use |
| 03/17/2005 | US20050058633 Stem cells that transform to beating cardiomyocytes |
| 03/17/2005 | US20050058632 Cell carrier and cell carrier containment devices containing regenerative cells |
| 03/17/2005 | US20050058631 Diagnosis, therapy; conditioning culture |
| 03/17/2005 | US20050058630 Homogeneity culture product; promoting cell differentiation; thrombosis; antiinflammatory agents; immunosuppressants; antiapoptosis agents |
| 03/17/2005 | US20050058629 Soft tissue repair and regeneration using postpartum-derived cells |
| 03/17/2005 | US20050058628 Nuclear reprogramming of cells for therapeutic use |
| 03/17/2005 | US20050056291 Engineering of adipose tissue by transplantation, augmentation or regeneration |
| 03/17/2005 | CA2538319A1 Antibodies against interleukin-1 receptor and uses thereof |
| 03/17/2005 | CA2537881A1 Antibody-producing cell lines expressing activation-induced-cytidine-deaminase and a dominant negative allele of a mismatch repair gene |
| 03/17/2005 | CA2537371A1 Antigenic peptides of rabies virus and uses thereof |
| 03/17/2005 | CA2537273A1 Method for the production of fusion proteins in transgenic mammal milk |
| 03/17/2005 | CA2536934A1 Method for differentiating mesenchymal stem cell into hepatocyte and artificial human hepatocyte |
| 03/17/2005 | CA2536782A1 Recombinant production of antimicrobial agents |
| 03/17/2005 | CA2536015A1 Modified oligonucleotides for telomerase inhibition |
| 03/17/2005 | CA2534907A1 Homogeneous preparations of il-28 and il-29 |
| 03/16/2005 | EP1514941A2 Paraquat resistance gene and a vascular tissue- and trichome-specific promotor |
| 03/16/2005 | EP1514938A1 Heat-resistant DNA ligase |
| 03/16/2005 | EP1514937A1 Production of vaccines |
| 03/16/2005 | EP1514935A1 Ehd1 gene promoting plant floewering, and utilization thereof |
| 03/16/2005 | EP1514934A2 Biosynthetic binding protein for cancer marker |
| 03/16/2005 | EP1514932A2 Glucagon receptors |
| 03/16/2005 | EP1514925A1 Method of screening compound affecting amyloid beta production |
| 03/16/2005 | EP1514920A1 Methods and device for adhesive control of internal cell organisation |
| 03/16/2005 | EP1514876A2 Antibody against prostate stem cell antigen (PSCA) |
| 03/16/2005 | EP1514216A2 Generation and selection of protein library in silico |
| 03/16/2005 | EP1514116A1 Oxaliplatin anti-resistance agent |
| 03/16/2005 | EP1514114A2 Method to screen ligands using eukaryotic cell display |
| 03/16/2005 | EP1513956A2 Assay to detect replication competent viruses |
| 03/16/2005 | EP1513937A2 A method for the stimultaneaous production of multiple proteins; vectors and cells for use therein |
| 03/16/2005 | EP1513936A2 Use of repression blocking sequences in methods for enhancing gene expression |
| 03/16/2005 | EP1513932A1 Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment |
| 03/16/2005 | EP1513931A2 Modified phytases |
| 03/16/2005 | EP1513929A2 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter |
| 03/16/2005 | EP1513928A2 A bank of stem cells for producing cells for transplantation having hla antigens matching those of transplant recipients, and methods for making and using such a stem cell bank |
| 03/16/2005 | EP1513927A2 Generation of histocompatible tissues using nuclear transplantation |
| 03/16/2005 | EP1513926A2 Cytokine-free growth and maintenance of progenitor cells |
| 03/16/2005 | EP1513921A1 A method of cell therapy using fused cell hybrids |
| 03/16/2005 | EP1513920A2 Culture systems for the sterile continuous cultivation of cells |
| 03/16/2005 | EP1513879A2 Synthetic antibody phage libraries |
| 03/16/2005 | EP1513877A1 Marker for stem cells and its use |
| 03/16/2005 | EP1513876A2 Human 5-ht7 receptor promoter sequence |